Annual Accounts Payable
$17.19 M
+$12.84 M+295.24%
December 31, 2023
Summary
- As of February 12, 2025, SNDX annual accounts payable is $17.19 million, with the most recent change of +$12.84 million (+295.24%) on December 31, 2023.
- During the last 3 years, SNDX annual accounts payable has risen by +$13.69 million (+390.11%).
- SNDX annual accounts payable is now at all-time high.
Performance
SNDX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$10.40 M
-$4.27 M-29.08%
September 30, 2024
Summary
- As of February 12, 2025, SNDX quarterly accounts payable is $10.40 million, with the most recent change of -$4.27 million (-29.08%) on September 30, 2024.
- Over the past year, SNDX quarterly accounts payable has increased by +$4.36 million (+72.00%).
- SNDX quarterly accounts payable is now -39.49% below its all-time high of $17.19 million, reached on December 31, 2023.
Performance
SNDX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
SNDX Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +295.2% | +72.0% |
| 3 y3 years | +390.1% | +26.4% |
| 5 y5 years | +1094.8% | +26.4% |
SNDX Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +295.2% | -39.5% | +139.2% |
| 5 y | 5-year | at high | +390.1% | -39.5% | +467.9% |
| alltime | all time | at high | +4756.8% | -39.5% | +2839.0% |
Syndax Pharmaceuticals Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $10.40 M(-29.1%) |
| Jun 2024 | - | $14.67 M(-10.3%) |
| Mar 2024 | - | $16.36 M(-4.9%) |
| Dec 2023 | $17.19 M(+295.2%) | $17.19 M(+184.2%) |
| Sep 2023 | - | $6.05 M(-44.9%) |
| Jun 2023 | - | $10.98 M(+36.3%) |
| Mar 2023 | - | $8.06 M(+85.2%) |
| Dec 2022 | $4.35 M(-23.3%) | $4.35 M(-38.9%) |
| Sep 2022 | - | $7.12 M(+10.5%) |
| Jun 2022 | - | $6.44 M(-21.8%) |
| Mar 2022 | - | $8.23 M(+45.2%) |
| Dec 2021 | $5.67 M(+61.6%) | $5.67 M(+10.7%) |
| Sep 2021 | - | $5.12 M(+41.3%) |
| Jun 2021 | - | $3.62 M(-44.5%) |
| Mar 2021 | - | $6.53 M(+86.1%) |
| Dec 2020 | $3.51 M(-43.2%) | $3.51 M(-8.6%) |
| Sep 2020 | - | $3.84 M(+109.4%) |
| Jun 2020 | - | $1.83 M(-79.6%) |
| Mar 2020 | - | $9.00 M(+45.6%) |
| Dec 2019 | $6.18 M | $6.18 M(-8.6%) |
| Sep 2019 | - | $6.76 M(+196.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $2.28 M(-47.7%) |
| Mar 2019 | - | $4.35 M(+202.3%) |
| Dec 2018 | $1.44 M(-35.5%) | $1.44 M(-54.7%) |
| Sep 2018 | - | $3.18 M(-40.0%) |
| Jun 2018 | - | $5.30 M(+104.5%) |
| Mar 2018 | - | $2.59 M(+16.0%) |
| Dec 2017 | $2.23 M(-6.0%) | $2.23 M(-0.6%) |
| Sep 2017 | - | $2.25 M(-33.2%) |
| Jun 2017 | - | $3.36 M(+22.7%) |
| Mar 2017 | - | $2.74 M(+15.4%) |
| Dec 2016 | $2.38 M(+63.6%) | $2.38 M(+18.2%) |
| Sep 2016 | - | $2.01 M(+26.6%) |
| Jun 2016 | - | $1.59 M(-28.6%) |
| Mar 2016 | - | $2.23 M(+53.2%) |
| Dec 2015 | $1.45 M(+310.2%) | $1.45 M(+17.1%) |
| Sep 2015 | - | $1.24 M(+250.3%) |
| Dec 2014 | $354.00 K(-67.1%) | $354.00 K(-10.8%) |
| Sep 2014 | - | $397.00 K(-57.2%) |
| Jun 2014 | - | $928.00 K(+15.3%) |
| Mar 2014 | - | $805.00 K(-25.3%) |
| Dec 2013 | $1.08 M(+38.8%) | $1.08 M |
| Dec 2012 | $776.00 K | - |
FAQ
- What is Syndax Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for Syndax Pharmaceuticals?
- What is Syndax Pharmaceuticals annual accounts payable year-on-year change?
- What is Syndax Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for Syndax Pharmaceuticals?
- What is Syndax Pharmaceuticals quarterly accounts payable year-on-year change?
What is Syndax Pharmaceuticals annual accounts payable?
The current annual accounts payable of SNDX is $17.19 M
What is the all time high annual accounts payable for Syndax Pharmaceuticals?
Syndax Pharmaceuticals all-time high annual accounts payable is $17.19 M
What is Syndax Pharmaceuticals annual accounts payable year-on-year change?
Over the past year, SNDX annual accounts payable has changed by +$12.84 M (+295.24%)
What is Syndax Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of SNDX is $10.40 M
What is the all time high quarterly accounts payable for Syndax Pharmaceuticals?
Syndax Pharmaceuticals all-time high quarterly accounts payable is $17.19 M
What is Syndax Pharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, SNDX quarterly accounts payable has changed by +$4.36 M (+72.00%)